4basebio (XTER:88Q) Change In Inventory : €-0.06 Mil (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is 4basebio Change In Inventory?

4basebio's change in inventory for the quarter that ended in Jun. 2023 was €-0.08 Mil. It means 4basebio's inventory increased by €0.08 Mil from Dec. 2022 to Jun. 2023 .

4basebio's change in inventory for the fiscal year that ended in Dec. 2022 was €0.03 Mil. It means 4basebio's inventory declined by €0.03 Mil from Dec. 2021 to Dec. 2022 .

4basebio's Total Inventories for the quarter that ended in Jun. 2023 was €0.23 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. 4basebio's Days Inventory for the quarter that ended in Jun. 2023 was 394.73.

Inventory Turnover measures how fast the company turns over its inventory within a year. 4basebio's Inventory Turnover for the quarter that ended in Jun. 2023 was 0.46.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. 4basebio's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.69.

4basebio Change In Inventory Historical Data

The historical data trend for 4basebio's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio Change In Inventory Chart

4basebio Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Change In Inventory

0.02

-0.03

-0.04

0.03

4basebio Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Change In Inventory	Get a 7-Day Free Trial			0.03	-0.07	0.01	0.02	-0.08

4basebio Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.06 Mil.

4basebio (XTER:88Q) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

4basebio's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0.1925	/	0.089	*	365 / 2
	=	394.73

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

4basebio's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.089	/	0.1925
	=	0.46

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

4basebio's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.1925	/	0.277
	=	0.69

4basebio Change In Inventory Related Terms

Thank you for viewing the detailed overview of 4basebio's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

4basebio (XTER:88Q) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (XTER:88Q) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

4BB:UK

Address

25 Norman Way, Over, Cambridge, GBR, CB24 5QE

Website

https://www.4basebio.com

4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (XTER:88Q) Headlines

No Headlines